The company, in a regulatory filing, said that the order issued by the Chennai bench, admitting the petition filed by an operational creditor Lakshmi Vilas Bank Ltd, initiates corporate insolvency resolution process (CIRP) against the pharmaceutical firm.
The company is in the process of exploring a suitable legal recourse, including preferring an appeal before the NCLT following consultations with its legal counsel.
Orchid Pharma, once a leader in injectables and some of the Active Pharmaceutical Ingredients (API) manufacturing, has been suffering from a financial crisis for a number of years now and its investors and lenders have approached various legal forums in their lookout for a remedy.
To read the full story, Subscribe Now at just Rs 249 a month
Already a subscriber? Log in
Subscribe To BS Premium
₹249
Renews automatically
₹1699₹1999
Opt for auto renewal and save Rs. 300 Renews automatically
₹1999
What you get on BS Premium?
- Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
- Pick your 5 favourite companies, get a daily email with all news updates on them.
- Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
- Preferential invites to Business Standard events.
- Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
Need More Information - write to us at assist@bsmail.in